Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
N(4)-Hydroxycytidine Potential treatment - pre-clinical evidence Experimental Antiviral Jan/26/2022 5 0
Remdesivir Approved by FDA Experimental Antiviral Jan/21/2022 70 5
Tenofovir Potential treatment - clinical evidence Used to treat other disease Antiviral Dec/20/2021 4 3
Emtricitabine Potential treatment - clinical evidence Used to treat other disease Antiviral Dec/20/2021 2 2
Favipiravir Potential treatment - clinical evidence Used to treat other disease Antiviral Sep/24/2021 27 7
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Sep/22/2021 36 4
Bosutinib Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/06/2021 3 0
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Jul/12/2021 87 22
Baicalein Potential treatment - pre-clinical evidence Natural product Antiviral Apr/22/2021 6 0
Corticosteroids Potential treatment - clinical evidence Used to treat other disease Other treatment Apr/09/2021 15 8